{"id":200288,"date":"2026-03-29T09:36:00","date_gmt":"2026-03-29T13:36:00","guid":{"rendered":"https:\/\/testing.news-you-need.com\/index.php\/2026\/03\/29\/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market\/"},"modified":"2026-03-29T09:45:13","modified_gmt":"2026-03-29T13:45:13","slug":"eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market","status":"publish","type":"post","link":"https:\/\/testing.news-you-need.com\/index.php\/2026\/03\/29\/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market\/","title":{"rendered":"Eli Lilly reaches deal to bring AI-developed drugs to global market"},"content":{"rendered":"<p><a href=\"https:\/\/www.cnbc.com\/2026\/03\/29\/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market.html\">Eli Lilly reaches deal to bring AI-developed drugs to global market<\/a><\/p>\n<p><a href=\"https:\/\/www.cnbc.com\/2026\/03\/29\/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market.html\">https:\/\/www.cnbc.com\/2026\/03\/29\/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market.html<\/a><\/p>\n<p>Publish Date: <a href=\"publish_date]\">2026-03-29 09:36:00<\/a><\/p>\n<p>Source Domain: <a href=\"www.cnbc.com\">www.cnbc.com<\/a><\/p>\n<ul>\n<li><strong>Significant Pharmaceutical Collaboration:<\/strong> Eli Lilly, a U.S. pharmaceutical giant, has agreed to a $2.75 billion deal to bring novel drugs from Hong Kong-based Insilico Medicine to the global market.<\/li>\n<li><strong>AI-Driven Drug Development:<\/strong> Insilico utilizes generative AI to develop drugs, with at least 28 drugs, nearly half of which are already at a clinical stage.<\/li>\n<li><strong>Initial Investment and Future Earnings:<\/strong> The agreement includes an upfront payment of $115 million to Insilico, with the rest contingent on regulatory and commercial milestones, as well as future sales royalties.<\/li>\n<li><strong>Lilly\u2019s Strategic AI Integration:<\/strong> Eli Lilly&#8217;s collaboration with Insilico leverages Insilico\u2019s AI-driven discoveries to complement Lilly&#8217;s clinical development strengths, aiming to accelerate the identification of promising therapeutic candidates.<\/li>\n<li><strong>Global Drug Research Operations:<\/strong> While Insilico&#8217;s AI R&amp;D happens in Canada and the Middle East, it conducts early preclinical research in China, taking advantage of AI to synthesize molecules more quickly.<\/li>\n<li><strong>Lilly&#8217;s Asia Investments:<\/strong> Eli Lilly is also planning to invest $3 billion in China within the next decade, with a slight increase in its revenue from China anticipated despite the country still accounting for less than 3% of its overall revenue.<\/li>\n<\/ul>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eli Lilly reaches deal to bring AI-developed drugs to global market https:\/\/www.cnbc.com\/2026\/03\/29\/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market.html Publish Date: 2026-03-29&#8230;<\/p>\n","protected":false},"author":1,"featured_media":200289,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/image.cnbcfm.com\/api\/v1\/image\/108230182-17637564612025-11-21t201933z_1589412582_rc2z0iaptunt_rtrmadp_0_lilly-stocks.jpeg?v=1773264563&w=1920&h=1080","fifu_image_alt":"","footnotes":""},"categories":[14],"tags":[19],"class_list":["post-200288","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligence","tag-generative-ai"],"_links":{"self":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/200288"}],"collection":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=200288"}],"version-history":[{"count":1,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/200288\/revisions"}],"predecessor-version":[{"id":200290,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/200288\/revisions\/200290"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/200289"}],"wp:attachment":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=200288"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=200288"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=200288"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}